Cargando…
Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome
BACKGROUND AND AIMS: Plasma levels of soluble triggering receptor expressed on myeloid cells (sTREM-1) reflect innate immune cell activation. We sought to evaluate sTREM-1 levels in patients with acute coronary syndrome (ACS) and their predictive value for disease severity and outcome. METHODS: Plas...
Autores principales: | Shiber, Shachaf, Kliminski, Vitaly, Orvin, Katia, Sagy, Iftach, Vaturi, Mordehay, Kornowski, Ran, Drescher, Michael, Molad, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987463/ https://www.ncbi.nlm.nih.gov/pubmed/33814983 http://dx.doi.org/10.1155/2021/8872686 |
Ejemplares similares
-
Diagnostic utility of clinical characteristics, laboratory tests, and serum ferritin in diagnosis of adult-onset Still disease
por: Sagy, Iftach, et al.
Publicado: (2022) -
Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome
por: Edel, Yonatan, et al.
Publicado: (2019) -
Association of the Charlson Comorbidity Index with Renal Outcome and All-Cause Mortality in Antineutrophil Cytoplasmatic Antibody-Associated Vasculitis
por: Ofer-Shiber, Shachaf, et al.
Publicado: (2014) -
Adult-onset Still's disease following mRNA COVID-19 vaccination
por: Sharabi, Amir, et al.
Publicado: (2021) -
Trends in Ischemic Mitral Regurgitation Following ST-Elevation Myocardial Infarction Over a 20-Year Period
por: Perl, Leor, et al.
Publicado: (2022)